Found: 14
Select item for more details and to access through your institution.
ASO Visual Abstract: Earlier Recurrence Detection Using Routine FDG PET-CT Scans in Surveillance of Stage IIB to IIID Melanoma—A National Cohort Study of 1480 Patients.
- Published in:
- 2023
- By:
- Publication type:
- Abstract
Earlier Recurrence Detection Using Routine FDG PET-CT Scans in Surveillance of Stage IIB to IIID Melanoma: A National Cohort Study of 1480 Patients.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2023, v. 30, n. 4, p. 2377, doi. 10.1245/s10434-022-13034-6
- By:
- Publication type:
- Article
Comparison of EORTC Criteria and PERCIST for PET/CT Response Evaluation of Patients with Metastatic Colorectal Cancer Treated with Irinotecan and Cetuximab.
- Published in:
- Journal of Nuclear Medicine, 2013, v. 54, n. 7, p. 1026, doi. 10.2967/jnumed.112.111757
- By:
- Publication type:
- Article
CT versus FDG-PET/CT response evaluation in patients with metastatic colorectal cancer treated with irinotecan and cetuximab.
- Published in:
- Cancer Medicine, 2014, v. 3, n. 5, p. 1294, doi. 10.1002/cam4.271
- By:
- Publication type:
- Article
Pembrolizumab as first line treatment of Merkel cell carcinoma patients – a case series of patients with various co-morbidities.
- Published in:
- 2020
- By:
- Publication type:
- Letter
Gene therapy for patients with advanced solid tumors: a phase I study using gene electrotransfer to muscle with the integrin inhibitor plasmid AMEP.
- Published in:
- Acta Oncologica, 2017, v. 56, n. 7, p. 909, doi. 10.1080/0284186X.2017.1315171
- By:
- Publication type:
- Article
Early F-FDG-PET/CT as a predictive marker for treatment response and survival in patients with metastatic colorectal cancer treated with irinotecan and cetuximab.
- Published in:
- Acta Oncologica, 2016, v. 55, n. 9/10, p. 1175, doi. 10.3109/0284186X.2016.1170197
- By:
- Publication type:
- Article
Observer variability in a phase II trial - assessing consistency in RECIST application.
- Published in:
- Acta Oncologica, 2012, v. 51, n. 6, p. 774, doi. 10.3109/0284186X.2012.667149
- By:
- Publication type:
- Article
Electrochemotherapy for large cutaneous recurrence of breast cancer: A phase II clinical trial.
- Published in:
- Acta Oncologica, 2012, v. 51, n. 6, p. 713, doi. 10.3109/0284186X.2012.685524
- By:
- Publication type:
- Article
Pancreatic ascites due to rupture of a mucinous cystic neoplasm.
- Published in:
- Acta Oncologica, 2008, v. 47, n. 5, p. 978, doi. 10.1080/02841860701666097
- By:
- Publication type:
- Article
Automated synthesis of <sup>68</sup>Ga/<sup>177</sup>Lu‐PSMA on the Trasis miniAllinOne.
- Published in:
- Journal of Labelled Compounds & Radiopharmaceuticals, 2020, v. 63, n. 8, p. 393, doi. 10.1002/jlcr.3846
- By:
- Publication type:
- Article
The DAHANCA 32 study: Electrochemotherapy for recurrent mucosal head and neck cancer.
- Published in:
- Head & Neck, 2019, v. 41, n. 2, p. 329, doi. 10.1002/hed.25454
- By:
- Publication type:
- Article
Prospective Assessment of Fluorine-18-Fluorodeoxyglucose-Positron Emission Tomography/Computed Tomography (FDG-PET/CT) for Early Identification of Checkpoint-Inhibitor-Induced Pseudoprogression.
- Published in:
- Cancers, 2024, v. 16, n. 5, p. 964, doi. 10.3390/cancers16050964
- By:
- Publication type:
- Article
Clinical value of routine [18F]2‐fluoro‐2‐deoxy‐d‐glucose positron emission tomography scans as a decision tool for early immunotherapy discontinuation in advanced melanoma.
- Published in:
- International Journal of Cancer, 2022, v. 150, n. 11, p. 1870, doi. 10.1002/ijc.33926
- By:
- Publication type:
- Article